Episode 34 - Michael Castagna, CEO Mannkind

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

We have a special guest—Michael Castagna, CEO of MannKind Corporation. Michael has over 25 years of experience in marketing, sales, and business development across both Fortune 500 companies and biotech startups.

Under his leadership, MannKind has grown into a major player in the field of endocrine and orphan lung diseases, bringing innovative therapies like Afrezza®, the only inhaled ultra-rapid-acting insulin, to market.

In this episode, Michael shares his journey, the challenges and triumphs of leading MannKind, and the future of the company’s groundbreaking technologies.

We also dive deep into his passion for turning around struggling companies and the lessons he’s learned from navigating the biotech landscape.

Enjoy and Stay Tuned.